265 related articles for article (PubMed ID: 29766730)
1. [Splanchnic vein thrombosis].
Lajzová S; Kroupa R; Buliková A; Bohatá Š; Packová B; Šenkyřík M
Vnitr Lek; 2018; 64(3):272-279. PubMed ID: 29766730
[TBL] [Abstract][Full Text] [Related]
2. Clinical approach to splanchnic vein thrombosis: risk factors and treatment.
Riva N; Donadini MP; Dentali F; Squizzato A; Ageno W
Thromb Res; 2012 Oct; 130 Suppl 1():S1-3. PubMed ID: 23026649
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations.
Cohen O; Caiano LM; Levy-Mendelovich S
Thromb Res; 2024 Feb; 234():75-85. PubMed ID: 38183815
[TBL] [Abstract][Full Text] [Related]
4. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
[TBL] [Abstract][Full Text] [Related]
5. How to manage splanchnic vein thrombosis in patients with liver disease.
Riva N; Ageno W
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.
Caiano LM; Riva N; Ageno W
Expert Rev Hematol; 2023 Feb; 16(2):121-129. PubMed ID: 36820873
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic Vein Thrombosis: Current Perspectives.
Valeriani E; Riva N; Di Nisio M; Ageno W
Vasc Health Risk Manag; 2019; 15():449-461. PubMed ID: 31695400
[TBL] [Abstract][Full Text] [Related]
8. [Splanchnic venous thrombosis: A monocentric study of 31 cases].
Benjilali L; Essaadouni L
J Mal Vasc; 2016 Feb; 41(1):26-35. PubMed ID: 26725444
[TBL] [Abstract][Full Text] [Related]
9. Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough?
Ravichandran P; Croome KP; Kovacs MJ; Lazo-Langner A; Hernandez-Alejandro R
Can J Gastroenterol Hepatol; 2014 Apr; 28(4):207-11. PubMed ID: 24729995
[TBL] [Abstract][Full Text] [Related]
10. Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.
Waiswa M; Seremba E; Ocama P; Ddungu H; Opio K; Okello C; O'shea T; Verhovsek M; Mutyabule R
Afr Health Sci; 2014 Dec; 14(4):1069-73. PubMed ID: 25834519
[TBL] [Abstract][Full Text] [Related]
11. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.
Finazzi G; De Stefano V; Barbui T
Blood Cancer J; 2018 Jun; 8(7):64. PubMed ID: 29946154
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes.
Kawata E; Siew DA; Payne JG; Louzada M; Kovacs MJ; Lazo-Langner A
Thromb Res; 2021 Jun; 202():90-95. PubMed ID: 33798804
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
De Stefano V; Qi X; Betti S; Rossi E
Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses.
Amitrano L; Guardascione MA; Scaglione M; Pezzullo L; Sangiuliano N; Armellino MF; Manguso F; Margaglione M; Ames PR; Iannaccone L; Grandone E; Romano L; Balzano A
Am J Gastroenterol; 2007 Nov; 102(11):2464-70. PubMed ID: 17958760
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
[TBL] [Abstract][Full Text] [Related]
17. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis.
Yin Y; Wang L; Gao F; Liu L; Qi X
Clin Appl Thromb Hemost; 2023; 29():10760296231188718. PubMed ID: 37461391
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
[TBL] [Abstract][Full Text] [Related]
20. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
